Apoptosis and its pathway in early post-implantation embryos of diabetic rats

https://doi.org/10.1016/j.diabres.2004.06.008Get rights and content

Abstract

It has been reported that diabetes-induced inappropriate apoptosis in embryos during neurulation may be one of the mechanisms leading to neural tube defects. We studied apoptosis and the apoptotic pathway occurring in early post-implantation period embryos of non-diabetic and streptozotocin (STZ)-induced diabetic rats. In quantitative RT-PCR, bax mRNA was constantly expressed to similar degree in embryos of non-diabetic and diabetic rats, while the expression of bcl-2 mRNA was significantly decreased in diabetic rat embryos compared to non-diabetic rat embryos. The increased number of terminal deoxynucleotidyl transferase-mediated nick end labeling (TUNEL)-positive cells occurred selectively in the primitive brains of diabetic rat embryos compared to non-diabetic rat embryos. Immunohistochemical studies revealed that, in mirror sections, the staining of Bax and activated caspase-3 were observed in the TUNEL-positive cell area, but the expression of Bcl-2 in these apoptotic cells was generally too low to be detected. These results suggest that a Bax-regulated mitochondrial cytochrome c-mediated caspase-3 activation pathway might be involved in the diabetic embryopathy.

Introduction

Infants born from mothers with diabetes have long been associated with an increased rate of congenital malformations in comparison with the rate for infants born from non-diabetic pregnancies [1], [2], [3]. Although any developing organ system could be affected by maternal diabetes, neural tube defects, including anencephaly, exencephaly, microencephaly, and spina bifida, are common diabetes-associated congenital malformations in humans [4], [5]. Such neural tube defects are also common malformations associated with diabetic embryopathy in animal models [6], [7].

Apoptosis commonly occurs during a variety of developmental processes in mammals. We recently reported that apoptosis occurred in various tissues of early post-implantation embryos undergoing organogenesis such as the primitive brain, primitive gut and cardiogenic areas. Bax and Bcl-2 are important in the regulation of apoptosis at this embryonic stage [8]. Our previous studies have demonstrated that diabetes-induced embryonic malformations were associated with increased free radical formations and/or reduced activity of free radical defense system [9], [10]. Enhanced production of reactive oxygen species was reported as one of the important stimuli to induce mitochondrial transition, caspase activation, and apoptosis [11], [12]. Embryos cultured with hyperglycemia or diabetic serum showed cell death as “pyknotic debris” in the neural tube [13], [14]. In addition, it has been reported that increased apoptosis on the surface of neural folds during the neural tube formation occurred in embryos of diabetic mice at gestational day (GD) 10.5 [15], [16]. These findings led to the speculation that diabetes-induced inappropriate apoptosis in embryos might lead to neural tube defects. However, the exact pathway of the apoptosis involved in the neural tube defects has not been resolved.

To investigate the factors, downstream of the apoptosis pathway, we analyzed the expression of two major apoptosis markers, cytochrome c and activated caspase-3. During apoptosis, cytochrome c is translocated from mitochondrial membrane to the cytosol, where it is required for the activation of caspase-3. The aim of this study was to examine the involvement of the Bax, Bcl-2, and mitochondrial cytochrome c-mediated caspase-3 activation pathway in diabetes-induced inappropriate apoptosis in neural tissue during early organogenesis.

Section snippets

Experimental animals

Eight-week-old virgin Wistar rats obtained from Shizuoka Laboratory (Shizuoka, Japan) were kept in a room where the temperature (23 ± 1 °C) and light/dark cycle (12 h light:12 h dark) were closely controlled. A standard laboratory diet (Oriental Yeast, Tokyo) was provided, and water was available ad libitum. All animal procedures were performed according to the guide of the Animal Care and Use Committee at our institution. Experimental diabetes was induced by intraperitoneal injection of 70 mg/kg

Apoptosis in diabetic and non-diabetic rat embryos

We have previously observed that during the early post-implantation period of normal rat embryos, from gestational days 9.5 to 11.5, apoptosis frequently occurred in the foregut at GD 9.5 and in the primitive brain at GD 11.5, although no apoptotic cells were detected in the primitive heart at GDs 10.5 and 11.5 [8]. The frequency of TUNEL-positive cells in the primitive gut was similar between the diabetic and non-diabetic rat embryos (Fig. 1A, GD 9.5, foregut, diabetic rat embryos, 4.62 ±

Discussion

We previously reported that neural tube defects were the most common malformations in embryos cultured in hyperglycemic conditions and/or in streptozotocin-induced diabetic rat embryos [7], [9], [10], [23]. Most of the neural tube defects were localized to the rostral neuropore, the last portion of the neural tube to fuse. These defects were either open neural tube defects (excenphaly) or defects affecting the development of structures overlying the fourth ventricle. Loeken and co-workers [15],

Acknowledgement

The authors thank Ms. Michiko Fukahori for her excellent technical assistance.

References (29)

  • F. Sun et al.

    Apoptosis in normal rat embryo tissues during early organogenesis: the possible involvement of Bax and Bcl-2

    Arch. Histol. Cytol.

    (2002)
  • R. Trocino et al.

    Significance of glutathione depletion and oxidative stress in early embryogenesis in glucose-induced rat embryo culture

    Diabetes

    (1995)
  • H. Sakamaki et al.

    Significance of glutathione-dependent antioxidant system in diabetes-induced embryonic malformations

    Diabetes

    (1999)
  • G. Kroemer

    The proto-oncogene Bcl-2 and its role in regulating apoptosis

    Nat. Med.

    (1997)
  • Cited by (50)

    • Is post exposure prevention of teratogenic damage possible: Studies on diabetes, valproic acid, alcohol and anti folates in pregnancy: Animal studies with reflection to human

      2018, Reproductive Toxicology
      Citation Excerpt :

      It should be noted that often, oxidative stress also induces increased iNOS expression and nitrosative stress, leading to apoptosis [69,112]. Studies have demonstrated increased apoptosis in embryos exposed to a diabetic environment [113]. Increased activation of Caspse –3, BAX and other markers of apoptosis have been described [90].

    • Advances in revealing the molecular targets downstream of oxidative stress-induced proapoptotic kinase signaling in diabetic embryopathy

      2015, American Journal of Obstetrics and Gynecology
      Citation Excerpt :

      Apoptosis is specifically seen in neuroepithelial cells, which are particularly susceptible to hyperglycemic damage.55 Multiple studies have confirmed that excess cell death, at least in the central nervous system, contributes to the abnormal development of structures in the embryos of diabetic animals.53,55-58 Hyperglycemia-induced apoptosis involves the altered regulation of Bcl-2 family members and caspase activation, critical events in the mitochondrial apoptotic pathway (Figure 4).

    • Decoding the oxidative stress hypothesis in diabetic embryopathy through proapoptotic kinase signaling

      2015, American Journal of Obstetrics and Gynecology
      Citation Excerpt :

      The failure of posterior neural tube closure results in spina bifida, 1 of the common birth defects among offspring of diabetic mothers.24,25 Multiple studies have confirmed that excessive cell death, at least in the central nervous system, contributes to the abnormal development of structures in the embryos of diabetic animals.17,26-29 These observations strongly suggest that high concentrations of glucose cause damage to the neural progenitor cells, leading to apoptosis and, ultimately, abnormal organogenesis.

    • New Concepts in Diabetic Embryopathy

      2013, Clinics in Laboratory Medicine
    View all citing articles on Scopus
    View full text